Article > Lilly’s Cialis approved for BPH in Europe

See on Scoop.itPharmacy Education

Regulators in Europe have given the green light to Eli Lilly’s erectile dysfunction drug Cialis as a treatment for enlarged prostate.

The European Commission has approved Cialis (tadalafil) for once-daily use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). The drug was approved for ED in the EU in 2002, and the latest thumbs-up comes just over a year after the US Food and Drug Administration cleared Cialis for BPH.

See on www.pharmatimes.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s